ArticleMolecular cytogenetics2026
Disheveled associated activator of morphogenesis 2 variants may produce alport-like changes: a case report.
Article in Molecular cytogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDAAM2 is an important formin, which plays an important role in the polymerization of monomeric actin into linear filaments. Previous studies have suggested that the DAAM2 variant mainly causes congenital Nephrotic Syndrome Type 24 (NPHS24), which is characterized by focal segmental glomerulosclerosis and steroid resistant nephrotic syndrome.
methodsWe report a case of a young man diagnosed with IgA nephropathy by renal biopsy.
resultsSpecifically, in addition to IgA nephropathy, this patient also had diffuse thinning of GBM, reduced segmental expression of type IV collagen α3 in the glomerulus, and binocular keratoconus which is consistent with features of Alport syndrome. However, whole exon sequencing eliminated the common variation in the type IV collagen-encoding gene and revealed a homozygous mutation in the formin homology 2 (FH2) domain of DAAM2, the core domain responsible for actin polymerization.
conclusionIn conclusion, our case suggests that the spectrum of DAAM2-associated nephropathies might be broader than previously recognized. We propose the novel hypothesis that mutations in the FH2 domain of DAAM2 could predispose to an Alport-like phenotype, potentially through cytoskeletal dysregulation affecting glomerular basement membrane (GBM) integrity. This expands the potential clinical heterogeneity linked to DAAM2 and warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.